These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27535326)

  • 1. Risk factors for chronic kidney disease do not influence the serum levels of asymmetric dimethylarginine in HIV-1-infected patients without significant renal disease.
    Szymanek-Pasternak A; Szymczak A; Zalewska M; Małyszczak K; Knysz B
    Pol Arch Med Wewn; 2016 Aug; 126(9):672-680. PubMed ID: 27535326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric dimethylarginine concentrations decrease in patients with HIV infection under antiretroviral therapy.
    Kurz K; Teerlink T; Sarcletti M; Weiss G; Zangerle R; Fuchs D
    Antivir Ther; 2012; 17(6):1021-7. PubMed ID: 22892398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors for chronic kidney disease among HIV-infected antiretroviral therapy-naïve patients in mainland China: a multicenter cross-sectional study.
    Cao Y; Gong M; Han Y; Xie J; Li X; Zhang L; Li Y; Song X; Zhu T; Li T
    Nephrology (Carlton); 2013 Apr; 18(4):307-12. PubMed ID: 23311442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic kidney disease in Australian Human Immunodeficiency Virus-infected patients: Analysis of the Australian HIV Observational Database.
    Cheung J; Puhr R; Petoumenos K; Cooper DA; Woolley I; Gunathilake M; Raymond N; Varma R; O'Connor CC; Gracey DM
    Nephrology (Carlton); 2018 Aug; 23(8):778-786. PubMed ID: 28703924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
    Hov GG; Aasarød KI; Sagen E; Åsberg A
    Clin Biochem; 2015 Jul; 48(10-11):646-51. PubMed ID: 25828044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in the relationships between chronic kidney disease, asymmetric dimethylarginine, and sleep quality: The HEIJO-KYO cohort.
    Obayashi K; Kurumatani N; Saeki K
    Nitric Oxide; 2018 Sep; 79():25-30. PubMed ID: 29983400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of asymmetric dimethylarginine are associated with lower CD4+ count and higher viral load in HIV-infected individuals.
    Parikh RV; Scherzer R; Grunfeld C; Nitta EM; Leone A; Martin JN; Deeks SG; Ganz P; Hsue PY
    Atherosclerosis; 2013 Jul; 229(1):246-52. PubMed ID: 23711612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric dimethylarginine and coronary artery calcium scores are increased in patients infected with human immunodeficiency virus.
    Jang JJ; Berkheimer SB; Merchant M; Krishnaswami A
    Atherosclerosis; 2011 Aug; 217(2):514-7. PubMed ID: 21549379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity].
    Galiamov MG; Saginova EA; Severova MM; Samokhodskaia LM; Krasnova TN; Sholomova VI; Sorokin IuD; Mukhin NA
    Ter Arkh; 2013; 85(6):31-7. PubMed ID: 23866596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers.
    Kurz K; Teerlink T; Sarcletti M; Weiss G; Zangerle R; Fuchs D
    Pharmacol Res; 2009 Dec; 60(6):508-14. PubMed ID: 19651212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-β1 synthesis.
    Mihout F; Shweke N; Bigé N; Jouanneau C; Dussaule JC; Ronco P; Chatziantoniou C; Boffa JJ
    J Pathol; 2011 Jan; 223(1):37-45. PubMed ID: 20845411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal toxicity of long-term therapy with tenofovir in HIV-infected patients.
    Monteagudo-Chu MO; Chang MH; Fung HB; Bräu N
    J Pharm Pract; 2012 Oct; 25(5):552-9. PubMed ID: 22551561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression.
    Testa A; Mallamaci F; Leonardis D; Spoto B; Pisano A; Sanguedolce MC; Tripepi G; Zoccali C;
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):167-72. PubMed ID: 25435339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric dimethylarginine and progression of chronic kidney disease: a one-year follow-up study.
    Eiselt J; Rajdl D; Racek J; Vostrý M; Rulcová K; Wirth J
    Kidney Blood Press Res; 2014; 39(1):50-7. PubMed ID: 24923294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects.
    Marra M; Marchegiani F; Ceriello A; Sirolla C; Boemi M; Franceschi C; Spazzafumo L; Testa I; Bonfigli AR; Cucchi M; Testa R
    Nephrol Dial Transplant; 2013 Apr; 28(4):964-71. PubMed ID: 23129820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in pre-dialysis patients with chronic kidney disease.
    Shi B; Ni Z; Zhou W; Yu Z; Gu L; Mou S; Fang W; Wang Q; Cao L; Yan Y; Qian J
    Eur J Intern Med; 2010 Oct; 21(5):444-8. PubMed ID: 20816602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma asymmetric dimethylarginine and its association with some of cardiovascular disease risk factors in chronic kidney disease.
    Quoc Hoang TA; Tam V; Thang HV
    Med J Malaysia; 2019 Jun; 74(3):209-214. PubMed ID: 31256175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenofovir exposure alters associations of serum bicarbonate with chronic kidney disease risk in HIV-infected veterans.
    Kim JE; Scherzer R; Estrella MM; Ix JH; Shlipak MG
    AIDS; 2016 Apr; 30(7):1049-57. PubMed ID: 26760455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of aging, baseline renal function and stage of HIV infection on post-treatment changes in renal function among HIV-infected patients: a retrospective cohort study.
    Ding Y; Duan S; Ye R; Yao S; Cao D; Yang Y; Wang J; Shi Y; Zhang Y; Li P; Xu Y; Wei H; Yin C; Liu X; He N
    HIV Med; 2019 Oct; 20(9):591-600. PubMed ID: 31274235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD.
    Tripepi G; Kollerits B; Leonardis D; Yilmaz MI; Postorino M; Fliser D; Mallamaci F; Kronenberg F; Zoccali C
    J Am Soc Nephrol; 2015 Apr; 26(4):935-44. PubMed ID: 25150156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.